Ezetimibe is a nonstatin low-density lipoprotein cholesterol-lowering small molecule drug. Ezetimibe is the only currently FDA-approved approved member of the of intestinal cholesterol reuptake ...
will be used to support regulatory and approval filings for the 10 mg obicetrapib and 10 mg ezetimibe fixed-dose combination treatment for patients already using maximally tolerated lipid-lowering ...
In clinical practice, a combination of drugs is often used to treat patients with dyslipidemia who are not achieving their treatment goals. Ezetimibe reduces LDL cholesterol levels, and niacin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results